对于前药物技术来说,具有挑战性和新的机遇
Helin Li1,2, Xuelian Shen1,2, Yu Chu1,2
1Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, 310014, Zhejiang, China.
Investigational new drugs
|February 18, 2025
概括
前药物技术使得使用光或超声波等外部刺激的向化疗成为可能. 本综述涵盖刺激反应系统,重点关注小分子,抗体-药物联合体和纳米疗法,用于精确的治疗.
科学领域:
- 药用化学 医学化学
- 药物输送系统 药物输送系统
- 纳米技术 纳米技术
背景情况:
- 产药技术提供了向化疗,超越了全身管理.
- 具有刺激反应的前药激活 (光药学,放射药学,声药学) 可以提高药物输送的精度.
- 前代药物改善药理动力学,减少副作用,并提高治疗疗效.
研究的目的:
- 审查对刺激有反应的药物释放系统和对外部刺激有反应的前药激活.
- 专注于小分子前药物,抗体-药物联合体和前药物纳米系统的激活机制.
- 讨论这些精确的治疗策略的临床翻译的挑战和机会.
主要方法:
- 对刺激反应性前药物激活策略的文献综述.
- 对外源性刺激 (光,辐射,超声波) 进行分析,以对前药物进行激活.
- 检查包括小分子,抗体-药物合物和纳米系统在内的产药平台.
主要成果:
- 总结了光,辐射和超声波触发前药激活的进展.
- 突出了这些刺激反应系统在各种前药物格式中的应用.
- 确定与基药物和Pt(IV) 前药物纳米疗法相关的挑战.
结论:
- 对刺激反应的前药物策略代表了向化疗的重大进步.
- 临床翻译需要解决前药物设计,激活和输送方面的挑战.
- 需要进一步的研究来优化这些方法,以便精确有效地治疗癌症.
更多相关视频
相关概念视频
Prodrugs
2.4K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.4K
Drug Discovery: Overview
7.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K
Preclinical Development: Overview
4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K
Drug Biotransformation: Overview
2.3K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.3K
Drug Administration and Therapy Phases: Overview
403
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
403
Structure-Activity Relationships and Drug Design
488
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
488


